Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy
Authors
Keywords
-
Journal
ADVANCED MATERIALS
Volume -, Issue -, Pages 1802228
Publisher
Wiley
Online
2019-01-21
DOI
10.1002/adma.201802228
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy
- (2017) Yuanzeng Min et al. Nature Nanotechnology
- Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression
- (2017) Jianqin Lu et al. Nature Communications
- DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
- (2017) Claire Vanpouille-Box et al. Nature Communications
- Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses
- (2017) Guangbao Yang et al. Nature Communications
- In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy
- (2017) Chao Wang et al. Nature Biomedical Engineering
- Catalase-Loaded TaOx Nanoshells as Bio-Nanoreactors Combining High-Z Element and Enzyme Delivery for Enhancing Radiotherapy
- (2016) Guosheng Song et al. ADVANCED MATERIALS
- Perfluorocarbon-Loaded Hollow Bi2Se3Nanoparticles for Timely Supply of Oxygen under Near-Infrared Light to Enhance the Radiotherapy of Cancer
- (2016) Guosheng Song et al. ADVANCED MATERIALS
- Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade-Enhanced Cancer Photodynamic Immunotherapy
- (2016) Dangge Wang et al. NANO LETTERS
- Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
- (2016) Qian Chen et al. Nature Communications
- Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis
- (2015) Anne Bertrand et al. BMC Medicine
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- H2O2-Activatable and O2-Evolving Nanoparticles for Highly Efficient and Selective Photodynamic Therapy against Hypoxic Tumor Cells
- (2015) Huachao Chen et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
- (2015) Christina Twyman-Saint Victor et al. NATURE
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment
- (2015) Claire Vanpouille-Box et al. VACCINE
- Bioorthogonal oxime ligation mediated in vivo cancer targeting
- (2015) Li Tang et al. Chemical Science
- Real-time tracking of cell cycle progression during CD8+ effector and memory T-cell differentiation
- (2015) Ichiko Kinjyo et al. Nature Communications
- Nanoparticle-Delivered Transforming Growth Factor-β siRNA Enhances Vaccination against Advanced Melanoma by Modifying Tumor Microenvironment
- (2014) Zhenghong Xu et al. ACS Nano
- Immunological Responses Triggered by Photothermal Therapy with Carbon Nanotubes in Combination with Anti-CTLA-4 Therapy to Inhibit Cancer Metastasis
- (2014) Chao Wang et al. ADVANCED MATERIALS
- Marriage of Scintillator and Semiconductor for Synchronous Radiotherapy and Deep Photodynamic Therapy with Diminished Oxygen Dependence
- (2014) Chen Zhang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Controlling melanoma at local and systemic levels: is a combination of ablative therapy and immunotherapy the way forward?
- (2014) Joao Paulo Mattos Almeida et al. Immunotherapy
- Radiotherapy-Induced Anti-Tumor Immunity Contributes to the Therapeutic Efficacy of Irradiation and Can Be Augmented by CTLA-4 Blockade in a Mouse Model
- (2014) Yuya Yoshimoto et al. PLoS One
- Morphologically Virus-Like Fullerenol Nanoparticles Act as the Dual-Functional Nanoadjuvant for HIV-1 Vaccine
- (2013) Ligeng Xu et al. ADVANCED MATERIALS
- Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors
- (2013) J. Duraiswamy et al. CANCER RESEARCH
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- T-Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis
- (2012) A. Facciabene et al. CANCER RESEARCH
- Potent Induction of Tumor Immunity by Combining Tumor Cryoablation with Anti-CTLA-4 Therapy
- (2011) R. Waitz et al. CANCER RESEARCH
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- Clinical Application of Image-guided Radiotherapy in Bladder and Prostate Cancer
- (2010) M.R. Button et al. CLINICAL ONCOLOGY
- Different T Cell Receptor Signals Determine CD8+ Memory Versus Effector Development
- (2009) E. Teixeiro et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started